俄羅斯OTC藥品市場

本報告已在2011年07月19日停止出版。

目錄

Abstract

Why buy this report

• Get insight into trends in market performance
• Pinpoint growth sectors and identify factors driving change
• Identify market and brand leaders and understand the competitive environment

Product coverage

Adult mouthcare; Allergy care; Analgesics; Calming and sleeping products; Child-specific OTC healthcare; Cough; cold and allergy (hay fever) remedies; Digestive remedies; Ear care; Emergency contraception; Eye care; Medicated skin care; NRT Smoking cessation aids; OTC obesity; OTC statins; OTC triptans; Vitamins and dietary supplements; Wound treatments

Executive summary

Health Standards Remain Low but Improve

Health levels remain low in Russia, with heavy smoking, poor diets and alcohol and drug abuse resulting in increasing rates of disease. This trend was further exacerbated by an ageing population. The deteriorating health of the Russian population, coupled with rising disposable income levels, resulted in more consumers purchasing a wider variety of OTC healthcare more frequently. Simultaneously, players launched more products to take advantage of sales dynamism and chained chemists/pharmacies continued to expand across the country. These factors therefore supported strong overall growth in OTC healthcare in 2006 over the previous year.

NRT Smoking Cessation Aids Dynamic but from Low Base

NRT smoking cessation aids saw the strongest current value growth in 2006 over the previous year. However, this was chiefly due to a low base, with these products first gaining a significant presence in 2005. These products are proving increasingly popular but sales remain largely limited to the major cities. There is a huge smoking population in Russia but most are unaware of or uninterested in the potential risks of smoking. Strong consumer education campaigns will be required to support stronger growth.

Fragmented Sales Led by Multinationals

OTC healthcare is extremely fragmented, with a large range of players. The leaders are multinationals, including Novartis, Berlin Chemie, Aventis, GlaxoSmithKline and Krka. These players benefit from high quality products and strong funds for investment in new product development and marketing. With rising disposable income levels, many consumers traded up from domestic generics and unbranded products to products from multinationals, which are often viewed as offering higher quality.

Consumers Prefer Specialised Distribution Outlets

Chemists/pharmacies continued to be the most significant distribution channel for OTC healthcare during the review period. Most consumers prefer this channel, believing it to offer expert advice. In addition, its lead was supported by the expansion of chains across Russia. Direct sales is also significant, however, particularly in vitamins and dietary supplements. Grocery outlets is meanwhile fairly undeveloped, with only larger urban outlets offering a limited range of vitamins and dietary supplements.

Faster Growth in Forecast Period

OTC healthcare is expected to see even stronger constant value growth during the forecast period. Growth will be partly underpinned by increasing consumer demand, driven by rising disposable income levels, a growing interest in health and widening awareness of OTC healthcare. In addition, growth will be driven by players, with more players expected to enter this dynamic area during the forecast period, often through the acquisition of or investment in local producers. Players will launch numerous value-added products, with a growing focus on quality as they attempt to meet changing consumer demands. Finally, the spread of chained chemists/pharmacies across the regions will make a wider range of OTC healthcare available to more consumers during the forecast period.

Table of Contents

• OTC HEALTHCARE IN RUSSIA : MARKET INSIGHT
• EXECUTIVE SUMMARY
• Health Standards Remain Low but Improve
• NRT Smoking Cessation Aids Dynamic but from Low Base
• Fragmented Sales Led by Multinationals
• Consumers Prefer Specialised Distribution Outlets
• Faster Growth in Forecast Period
• KEY TRENDS AND DEVELOPMENTS
• Growing State Funding Supports Increased Sales
• Rx Medicines Still Dominate
• Competition from Homeopathy Intensifies
• Counterfeiting Still Huge but Losing Appeal
• Rising Foreign Investment Results in More
• Consolidated Shares
• Chained Chemists/Pharmacies Increasingly Significant
• CITY KEY TRENDS AND DEVELOPMENTS
• Moscow
• St Petersburg
• MARKET INDICATORS
  • Table 1 Life Expectancy at Birth 2001-2006
• MARKET DATA
  • Table 2 Sales of OTC Healthcare by Sector: Value 2001-2006
  • Table 3 Sales of OTC Healthcare by Sector: % Value Growth 2001-2006
  • Table 4 Sales of OTC Healthcare by City: Value 2001-2006
  • Table 5 Sales of OTC Healthcare by City: % Value Growth 2001-2006
  • Table 6 OTC Healthcare Company Shares by Retail Value 2002-2006
  • Table 7 OTC Healthcare Brand Shares by Retail Value 2003-2006
  • Table 8 Sales of OTC Healthcare by Distribution Format: % Analysis 2001/2006
  • Table 9 Sales of OTC Healthcare by Sector and Distribution Format: % Analysis 2006
  • Table 10 Forecast Sales of OTC Healthcare by Sector: Value 2006-2011
  • Table 11 Forecast Sales of OTC Healthcare by Sector: % Value Growth 2006-2011
  • Table 12 Forecast Sales of OTC Healthcare by City: Value 2006-2011
  • Table 13 Forecast Sales of OTC Healthcare by City: % Value Growth 2006-2011
• APPENDIX
• OTC Registration and Classification
• De-listing or De-reimbursement
• Advertising
• Packaging and Labelling
• Distribution
• Vitamins and Dietary Supplements Registration and Classification
• Generics
• Consumer Expenditure on Health Goods and Medical Services
  • Table 14 Consumer Expenditure on Health Goods and Medical Services 2001-2006
• DEFINITIONS
• Sources
  • Summary 1 Research Sources
• LOCAL COMPANY PROFILES - RUSSIA
• AKRIKHIN OAO - OTC HEALTHCARE - RUSSIA
• STRATEGIC DIRECTION
• KEY FACTS
  • Summary 2 Akrikhin OAO: Key Facts
  • Summary 3 Akrikhin OAO: Operational Indicators 2004-2006
• COMPANY BACKGROUND
• PRODUCTION
• COMPETITIVE POSITIONING
  • Summary 4 Akrikhin OAO: Competitive Position 2006
• EVALAR ZAO - OTC HEALTHCARE - RUSSIA
• STRATEGIC DIRECTION
• KEY FACTS
  • Summary 5 Evalar ZAO: Key Facts
  • Summary 6 Evalar ZAO: Operational Indicators
• COMPANY BACKGROUND
• PRODUCTION
  • Summary 7 Evalar ZAO: Production Statistics 2006
• COMPETITIVE POSITIONING
  • Summary 8 Evalar ZAO: Competitive Position 2006
• KRKA PHARMA OOO - OTC HEALTHCARE - RUSSIA
• STRATEGIC DIRECTION
• KEY FACTS
  • Summary 9 Krka Pharma OOO: Key Facts
  • Summary 10 Krka dd/ Krka Pharma OOO: Operational Indicators 2006
• COMPANY BACKGROUND
• PRODUCTION
• COMPETITIVE POSITIONING
  • Summary 11 Krka Pharma OOO: Competitive Position 2006
• NATURPRODUKT EUROPE BV - OTC HEALTHCARE - RUSSIA
• STRATEGIC DIRECTION
• KEY FACTS
  • Summary 12 NaturProdukt Europe BV: Key Facts
  • Summary 13 NaturProdukt Europe BV: Operational Indicators 2004-2005
• COMPANY BACKGROUND
• PRODUCTION
• COMPETITIVE POSITIONING
  • Summary 14 NaturProdukt Europe BV: Competitive Position 2006
• NIZHPHARM AO - OTC HEALTHCARE - RUSSIA
• STRATEGIC DIRECTION
• KEY FACTS
  • Summary 15 Nizhpharm OAO: Key Facts
  • Summary 16 Nizhpharm OAO: Operational Indicators
• 2004-2006
• COMPANY BACKGROUND
• PRODUCTION
• COMPETITIVE POSITIONING
  • Summary 17 Nizhpharm OAO: Competitive Position 2006
• OTECHESTVENNYE LEKARSTVA GROUP - OTC HEALTHCARE - RUSSIA
• STRATEGIC DIRECTION
• KEY FACTS
  • Summary 18 Otechestvennye Lekarstva Group: Key Facts
  • Summary 19 Otechestvennye Lekarstva Group: Operational Indicators 2005-2006
• COMPANY BACKGROUND
• PRODUCTION
• COMPETITIVE POSITIONING
  • Summary 20 Schelkovsky Vitaminy Zavod: Competitive Position 2006
  • Summary 21 Novosibkhimpharm AOOT: Competitive Position 2006
• PHARMSTANDARD GROUP - OTC HEALTHCARE - RUSSIA
• STRATEGIC DIRECTION
• KEY FACTS
  • Summary 22 Pharmstandard Group: Key Facts
  • Summary 23 Pharmstandard Group: Operational Indicators
• 2004-2006
• COMPANY BACKGROUND
• PRODUCTION
  • Summary 24 Pharmstandard Group: Production Statistics 2006
• COMPETITIVE POSITIONING
  • Summary 25 Pharmstandard Group: Competitive Position 2006
• RANBAXY LABORATORIES LTD - OTC HEALTHCARE - RUSSIA
• STRATEGIC DIRECTION
• KEY FACTS
  • Summary 26 Ranbaxy Laboratories limited: Key Facts
  • Summary 27 Ranbaxy Laboratories limited: Operational Indicators 2004-2006
• COMPANY BACKGROUND
• PRODUCTION
• COMPETITIVE POSITIONING
  • Summary 28 Ranbaxy Laboratories Ltd: Competitive Position 2006
• VEROPHARM ZAO - OTC HEALTHCARE - RUSSIA
• STRATEGIC DIRECTION
• KEY FACTS
  • Summary 29 Veropharm ZAO: Key Facts
  • Summary 30 Veropharm ZAO: Operational Indicators 2004-2006
• COMPANY BACKGROUND
• PRODUCTION
  • Summary 31 Veropharm ZAO: Production Statistics 2006
• COMPETITIVE POSITIONING
  • Summary 32 Veropharm ZAO: Competitive Position 2006
• ANALGESICS IN RUSSIA
• HEADLINES
• TRENDS
• COMPETITIVE LANDSCAPE
• PROSPECTS
• SECTOR DATA
  • Table 15 Sales of Analgesics by Subsector: Value 2001-2006
  • Table 16 Sales of Analgesics by Subsector: % Value Growth 2001-2006
  • Table 17 Herbal vs Standard Topical Analgesics 2001/2006
  • Table 18 Analgesics Company Shares by Retail Value 2002-2006
  • Table 19 Analgesics Brand Shares by Retail Value 2003-2006
  • Table 20 Forecast Sales of Analgesics by Subsector: Value 2006-2011
  • Table 21 Forecast Sales of Analgesics by Subsector: % Value Growth 2006-2011
• COUGH, COLD AND ALLERGY (HAY FEVER) REMEDIES IN RUSSIA
• HEADLINES
• TRENDS
• COMPETITIVE LANDSCAPE
• PROSPECTS
• SECTOR DATA
  • Table 22 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Subsector: Value 2001-2006
  • Table 23 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Subsector: % Value Growth 2001-2006
  • Table 24 Sales of Decongestants by Type: Value 2001-2006
  • Table 25 Sales of Decongestants by Type: % Value Growth 2001-2006
  • Table 26 Sales of Child-specific Cough, Cold and Allergy (Hay Fever) Remedies by Type: Value 2001-2006
  • Table 27 Sales of Child-specific Cough, Cold and Allergy (Hay Fever) Remedies by Type: % Value Growth 2001-2006
  • Table 28 Herbal vs Standard Cough, Cold and Allergy (Hay Fever) Remedies 2001/2006
  • Table 29 Cough, Cold and Allergy (Hay Fever) Remedies Company Shares by Retail Value 2002-2006
  • Table 30 Cough, Cold and Allergy (Hay Fever) Remedies Brand Shares by Retail Value 2003-2006
  • Table 31 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Subsector: Value 2006-2011
  • Table 32 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Subsector: % Value Growth 2006-2011
• DIGESTIVE REMEDIES IN RUSSIA
• HEADLINES
• TRENDS
• COMPETITIVE LANDSCAPE
• PROSPECTS
• SECTOR DATA
  • Table 33 Sales of Digestive Remedies by Subsector: Value 2001-2006
  • Table 34 Sales of Digestive Remedies by Subsector: % Value Growth 2001-2006
  • Table 35 Herbal vs Standard Digestive Remedies 2001/2006
  • Table 36 Digestive Remedies Company Shares by Retail Value 2002-2006
  • Table 37 Digestive Remedies Brand Shares by Retail Value 2003-2006
  • Table 38 Forecast Sales of Digestive Remedies by Subsector: Value 2006-2011
  • Table 39 Forecast Sales of Digestive Remedies by Subsector: % Value Growth 2006-2011
• MEDICATED SKIN CARE IN RUSSIA
• HEADLINES
• TRENDS
• COMPETITIVE LANDSCAPE
• PROSPECTS
• SECTOR DATA
  • Table 40 Sales of Medicated Skin Care by Subsector: Value 2001-2006
  • Table 41 Sales of Medicated Skin Care by Subsector: % Value Growth 2001-2006
  • Table 42 Herbal vs Standard Medicated Skin Care 2001/2006
  • Table 43 Medicated Skin Care Company Shares by Retail Value 2002-2006
  • Table 44 Medicated Skin Care Brand Shares by Retail Value 2003-2006
  • Table 45 Acne Treatments Brand Shares by Retail Value 2003-2006
  • Table 46 Forecast Sales of Medicated Skin Care by Subsector: Value 2006-2011
  • Table 47 Forecast Sales of Medicated Skin Care by Subsector: % Value Growth 2006-2011
• VITAMINS AND DIETARY SUPPLEMENTS IN RUSSIA
• HEADLINES
• TRENDS
• COMPETITIVE LANDSCAPE
• PROSPECTS
• SECTOR DATA
  • Table 48 Sales of Vitamins and Dietary Supplements by Subsector: Value 2001-2006
  • Table 49 Sales of Vitamins and Dietary Supplements by Subsector: % Value Growth 2001-2006
  • Table 50 Sales of Vitamins by Type: Value 2001-2006
  • Table 51 Sales of Vitamins by Type: % Value Growth 2001-2006
  • Table 52 Vitamins and Dietary Supplements Company Shares by Retail Value 2002-2006
  • Table 53 Vitamins and Dietary Supplements Brand Shares by Retail Value 2003-2006
  • Table 54 Vitamins Brand Shares by Retail Value 2003-2006
  • Table 55 Sales of Dietary Supplements by Type: Value 2001-2006
  • Table 56 Sales of Dietary Supplements by Type: % Value Growth 2001-2006
  • Table 57 Dietary Supplements Brand Shares by Retail Value 2003-2006
  • Table 58 Forecast Sales of Vitamins and Dietary Supplements by Subsector: Value 2006-2011
  • Table 59 Forecast Sales of Vitamins and Dietary Supplements by Subsector: % Value Growth 2006-2011
• NRT SMOKING CESSATION AIDS IN RUSSIA
• HEADLINES
• TRENDS
• COMPETITIVE LANDSCAPE
• PROSPECTS
• SECTOR INDICATORS
  • Table 60 Number of Smokers by Gender 2001-2006 SECTOR DATA
  • Table 61 Sales of Smoking Cessation Aids by Subsector: Value 2001-2006
  • Table 62 Sales of Smoking Cessation Aids by Subsector: % Value Growth 2001-2006
  • Table 63 Smoking Cessation Aids Company Shares by Retail Value 2002-2006
  • Table 64 Smoking Cessation Aids Brand Shares by Retail Value 2003-2006
  • Table 65 Forecast Sales of Smoking Cessation Aids by Subsector: Value 2006-2011
  • Table 66 Forecast Sales of Smoking Cessation Aids by Subsector: % Value Growth 2006-2011
• EYE CARE IN RUSSIA
• OVERVIEW
• SECTOR DATA
  • Table 67 Sales of Eye Care by Subsector: Value 2001-2006
  • Table 68 Sales of Eye Care by Subsector: % Value Growth 2001-2006
  • Table 69 Eye Care Company Shares by Retail Value 2002-2006
  • Table 70 Eye Care Brand Shares by Retail Value 2003-2006
  • Table 71 Forecast Sales of Eye Care by Subsector: Value 2006-2011
  • Table 72 Forecast Sales of Eye Care by Subsector: % Value Growth 2006-2011
• EAR CARE IN RUSSIA
• OVERVIEW
• ADULT MOUTHCARE IN RUSSIA
• OVERVIEW
• CALMING AND SLEEPING PRODUCTS IN RUSSIA
• OVERVIEW
• WOUND TREATMENTS IN RUSSIA
• OVERVIEW
• SECTOR DATA
  • Table 73 Sales of Wound Treatments by Subsector: Value 2001-2006
  • Table 74 Sales of Wound Treatments by Subsector: % Value Growth 2001-2006
  • Table 75 Wound Treatments Company Shares by Retail Value 2002-2006
  • Table 76 Wound Treatments Brand Shares by Retail Value 2003-2006
  • Table 77 Forecast Sales of Wound Treatments by Subsector: Value 2006-2011
  • Table 78 Forecast Sales of Wound Treatments by Subsector: % Value Growth 2006-2011
• EMERGENCY CONTRACEPTION IN RUSSIA
• OVERVIEW
• SECTOR DATA
  • Table 79 Sales of Emergency Contraception by Subsector: Value 2001-2006
  • Table 80 Sales of Emergency Contraception by Subsector: % Value Growth 2001-2006
  • Table 81 Forecast Sales of Emergency Contraception by Subsector: Value 2006-2011
  • Table 82 Forecast Sales of Emergency Contraception by Subsector: % Value Growth 2006-2011

相關商品

OTC 非處方藥相關市場調查報告書

保護兒童們的健康:兒童護理市場分析
Keeping Our Children Healthy: A Review of Paediatric Care
價格 : US $ 2000
出版日期 : 2012年01月

歐洲的OTC藥的流通趨勢(2012年版):揭開新時代序幕
OTC Distribution in Europe the 2012 Edition - Entering the New Era
價格 : US $ 3350
出版日期 : 2012年01月

中歐·東歐的OTC市場:2011年
OTC market in Central and Eastern Europe 2011
價格 : US $ 3427
出版日期 : 2011年10月

Euromonitor International發行的製藥相關市場調查報告書

德國的保健食品·健康飲料市場

Health and Wellness in Germany

價格 : US $ 1900

出版日期 : 2011年12月

台灣的保健食品·健康飲料市場

Health and Wellness in Taiwan

價格 : US $ 1900

出版日期 : 2011年10月

希臘的保健食品·健康飲料市場

Health and Wellness in Greece

價格 : US $ 1900

出版日期 : 2011年10月

Email Alert(Email 通知) - 最新市場調查報告書

GII 將每天定期更新最新市場調查報書資訊，選擇您有興趣的市場分類，我們將用Email的方式讓您收到最新訊息!